GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » EV-to-Revenue

Medrx Co (TSE:4586) EV-to-Revenue : 6.37 (As of Dec. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medrx Co's enterprise value is 円1,617.4 Mil. Medrx Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was 円254.0 Mil. Therefore, Medrx Co's EV-to-Revenue for today is 6.37.

The historical rank and industry rank for Medrx Co's EV-to-Revenue or its related term are showing as below:

TSE:4586' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.45   Med: 83.02   Max: 635.21
Current: 6.37

During the past 13 years, the highest EV-to-Revenue of Medrx Co was 635.21. The lowest was 4.45. And the median was 83.02.

TSE:4586's EV-to-Revenue is ranked worse than
79.07% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.465 vs TSE:4586: 6.37

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-12), Medrx Co's stock price is 円84.00. Medrx Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was 円5.86. Therefore, Medrx Co's PS Ratio for today is 14.34.


Medrx Co EV-to-Revenue Historical Data

The historical data trend for Medrx Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co EV-to-Revenue Chart

Medrx Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.24 20.32 173.00 28.37 137.89

Medrx Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.99 54.85 137.89 163.57 22.61

Competitive Comparison of Medrx Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medrx Co's EV-to-Revenue falls into.



Medrx Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medrx Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1617.435/254.049
=6.37

Medrx Co's current Enterprise Value is 円1,617.4 Mil.
Medrx Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円254.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medrx Co  (TSE:4586) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medrx Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=84.00/5.856
=14.34

Medrx Co's share price for today is 円84.00.
Medrx Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円5.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medrx Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medrx Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medrx Co Business Description

Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co Headlines

No Headlines